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medicine principles for sustainable malaria 
control: a scoping study
Denise Ocampo1 and Mark Booth2* 
Abstract 
Background: Current interventions against malaria have significantly reduced the number of people infected and 
the number of deaths. Concerns about emerging resistance of both mosquitoes and parasites to intervention have 
been raised, and questions remain about how best to generate wider knowledge of the underlying evolutionary pro-
cesses. The pedagogical and research principles of evolutionary medicine may provide an answer to this problem.
Methods: Eight programme managers and five academic researchers were interviewed by telephone or videocon-
ference to elicit their first-hand views and experiences of malaria control given that evolution is a constant threat to 
sustainable control. Interviewees were asked about their views on the relationship between practit groups and aca-
demics and for their thoughts on whether or not evolutionary medicine may provide a solution to reported tensions.
Results: There was broad agreement that evolution of both parasites and vectors presents an obstacle to sustain-
able control. It was also widely agreed that through more efficient monitoring, evolution could be widely monitored. 
Interviewees also expressed the view that even well planned interventions may fail if the evolutionary biology of the 
disease is not considered, potentially making current tools redundant.
Conclusions: This scoping study suggests that it is important to make research, including evolutionary principles, 
available and easily applicable for programme managers and key decision-makers, including donors and politicians. 
The main conclusion is that sharing knowledge through the educational and research processes embedded within 
evolutionary medicine has potential to relieve tensions and facilitate sustainable control of malaria and other parasitic 
infections.
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Background
Since 2000 there has been a substantial increase in global 
funding and international efforts to combat malaria [1, 2]. 
As a result, the latest World Health Organization (WHO) 
reports show a steady decline of malaria incidences and 
deaths [1, 2]. This success has been achieved by shift-
ing focus from eradication to control [1, 2]. Eradica-
tion is still considered possible, through universal and 
sustainable coverage of drugs, transmission-reducing 
tools and through strengthening health systems [1].
Despite this optimism, an important question remains 
as to the sustainability of these interventions to the point 
of eradication—given that both vectors and parasites are 
evolving faster than counteractions [3]. Human behav-
iour is imposing selective pressure on the vector and 
the pathogen via different pathways [3, 4]. Additionally, 
co-evolution between parasites, vectors and hosts may 
have direct consequences on virulence and transmission 
[3, 5–10].
Resistance to drugs is an outcome of evolutionary 
processes; consequently, the selection pressures asso-
ciated with treatment need to be considered within 
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malaria programmes [11]. Studying how parasites, vec-
tors and hosts co-evolve and, by considering what their 
most probable next developmental phase will be, could 
allow improved protection and thus an advantage in the 
battle against malaria [5, 6, 12, 13]. Therefore, the ques-
tion posed was: are principles derived from evolutionary 
medicine (EM) [14] being considered in the fight against 
malaria and used to make interventions more sustain-
able? Additionally, it was questioned whether there is 
sufficient collaboration between academic research, 
programme management and key decision-makers to 
facilitate sharing knowledge and generate common 
understanding.
This scoping research project was intended to under-
stand how EM might act as a bridging domain of enquiry 
amongst stakeholders from research and control pro-
gramme backgrounds. The results are intended to act as 
a catalyst and framework for further discussions towards 
sustainable control.
Methods
Research setting and sample
Qualitative interviews were conducted in the fields of 
malaria research and control. Actors in universities, 
disease prevention institutions and health partnerships 
were identified and contacted via email with an expla-
nation of the research and a request for an interview. 
Everyone who showed willingness was accepted as an 
interview participant; thereby forming a convenience 
sample. The interviewees consisted of thirteen people, 
eight of whom worked in applied malaria programmes 
and five in malaria research. All participants were stake-
holders in the research and control of malaria affecting 
people living in Africa. The principles of EM were out-
lined to each individual, when necessary, prior to the 
delivery of questionnaires. There were more programme 
managers in the sample as the main focus of the research 
was the practical application of evolutionary principles. 
For the research question, it was primarily important to 
understand what roles the participants played in malaria 
control.
Instruments, data collection and analysis
Each participant was informed about the purpose of the 
study and asked to give consent to have the interviews 
audiotaped, transcribed and used for the research. The 
consent and information form can be found in the Addi-
tional file 1. Durham University, as well as each partici-
pant, has given consent for this study to be published. 
Semi-structured and guided video or telephone inter-
views were held as most participants were not located in 
the UK. All interviews were audiotaped and transcribed. 
Original transcripts are available from the author.
As a precis to discussion on the potential contribution 
of EM to sustainable malaria control, participants were 
asked to respond to a series of questions corresponding 
to current control practice. The main topics addressed in 
the interviews were: perceived reasons for the successes 
and failures of malaria control programmes; first-hand 
experiences encountered working in this field; first-hand 
knowledge of the effects of resistance to drugs and insec-
ticide on programme success; the interviewee’s practi-
cal experiences of countering these challenges; and their 
ideas on possible solutions. The topic of EM was then 
addressed: by asking each interviewee if they considered 
its principles were already applied in control programmes 
and if not should they be incorporated. Interviewees 
were finally asked for their predictions for the future. 
The topics were chosen to match the main problems in 
the malaria literature and were tailored to what the inter-
viewees perceived to be problem areas. The wording, 
structure, style and main focus were adapted to the indi-
vidual interviewee, their field of speciality, and the nature 
of the interview. A copy of the interview questions can be 
found in Additional file 2.
For the presentation of the results of the interviews 
statements of the academics and programme managers 
were compared. Participants were categorized into these 
two groups as this best shows both ends of the spectrum 
in the malaria community. It should be noted that some 
interviewees worked in both sectors, but for the purpose 
of analysis they were categorized according to their pre-
sent role.
Results
From the original questionnaire eight compelling areas 
of reflection and discussion emerged. These were catego-
rized into the following eight domains:
  • Reasons for problems and failures in malaria pro-
grammes.
  • Reasons for successes of malaria programmes.
  • Reflections on the importance of drug and insecti-
cide resistance.
  • Knowledge about the underlying causes of drug and 
insecticide resistance.
  • Knowledge about the relationship between pathogen, 
vector and host and the implications for immunity, 
transmission and virulence.
  • Application of EM principles in malaria programmes.
  • The relative merits of action or reaction.
  • The role of communication between project manag-
ers and academia.
Each of these topics is addressed below with a narrative 
assessment of the questionnaire responses.
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Problems and failures of malaria programmes
Eight programme managers said insufficient funding was 
the biggest challenge and four said that management of 
the programmes was the biggest problem. Four research-
ers said, that in addition to insufficient funding, insecti-
cide resistance was the main problem. The following five 
points were voiced by both groups: insufficient funding and 
human resources; insecticide and drug resistance; malfunc-
tioning public health care systems, poor infrastructure; and 
low surveillance and data collection for monitoring.
One participant from each group felt that the lack of 
knowledge, and foresight to resistance, in addition to 
the absence of ways to apply this knowledge was a rea-
son for failure. Both groups also mentioned resistance 
to the drug artemisinin, and felt that it was the same 
programme strategies of vector control that were being 
applied rigidly to every situation which were causing pro-
grammes to fail where these tactics were not appropriate. 
Four of the programme managers pointed out that the 
lack of political will in countries endemic to malaria was 
another major cause for programmes to fail.
A difference that came up between the groups was that, 
whilst the lack of technical knowledge was said to be a 
problem by one programme manager, the lack of multi-
ple effective interventions was identified as a problem by 
two researchers. This indicates that interviewees of both 
groups put some of the responsibility for the problems 
with malaria programmes onto the other group.
Success of malaria programmes
The four points that were perceived to be successes and 
mentioned by both groups were: the introduction of arte-
misinin-based combination therapy (ACT) and long-lasting 
insecticide-treated nets (LLINs); improved treatment; the 
scaling-up of control tools in countries endemic to malaria; 
and finally the increased funding received in recent times.
Drug resistance
Three academics interviewed said that drugs were cur-
rently overused and misused. A programme manager as 
well as an academic emphasized the importance of cor-
rect drug usage, the development of new drugs and mon-
itoring, but considered insecticide resistance to be the 
greater problem. Two programme managers expressed 
hope that resistance to Artemisinin would not spread to 
Africa but would remain contained in South East Asia 
through elimination of the parasite. Three researchers 
conversely pointed out that resistance to drugs will inevi-
tably occur and measures need to be taken proactively.
Insecticide resistance
Problems with insecticide resistance arising through the 
usage of insecticides in public health interventions and 
agriculture are being observed by both project managers 
and academics. Both groups agreed that monitoring was 
necessary in order to stay informed and take appropriate 
action but there is currently a lack of monitoring. While 
programme managers put an emphasis on the need for 
new insecticides they also agreed that alternative control 
methods are necessary. They saw the intense usage of 
insecticides in agriculture as a source of resistance. This 
issue was heightened by the fact that there is very little 
communication and cooperation between the agriculture 
and health sectors. As food production has a higher pri-
ority than disease management there is currently no plan 
to change agricultural insecticides.
There was a divide amongst programme managers 
about the application of insecticides. Two participants 
of this group said that rotating insecticides was a good 
technique to avoid resistance while another argued that 
this more expensive application of insecticides is futile 
if agriculture continued to use the same active ingredi-
ents as public health for insecticides. One of the reasons 
given for the slow response to resistance was the lack of 
available insecticides. Pyrethroids were the only class of 
insecticides recommended by the WHO for bed nets as 
they were safe, cheap and extremely effective. As a result 
of their exclusive usage, resistance occurred. One of the 
researchers said that resistance was the price that was 
paid for the huge success of achieving high coverage and 
reducing mortality rates by 47  % globally [2]. However, 
others fear that this success will be lost if resistance is not 
taken seriously.
A further reason for the slowness of the reaction to 
resistance was given by one of the programme managers 
who explained that the development of insecticide resist-
ance is much more difficult to detect than that of drug 
resistance. Unlike drugs that go through a standardized 
process of control phases, insecticide development does 
not have the same procedure. Scientists perform tests at 
random on insecticides which then need to be approved 
by the WHO. This makes the development of insecticides 
and other control tools unreliable.
Resistance as a result of evolution
Academics and programme managers agreed that, 
although resistance was anticipated, it was not planned 
for and that programmes lacked foresight. This results 
in programmes having limited choices once resistance 
occurred. Both groups agreed that resistance occurs as 
a result of evolutionary processes. They also concurred 
that this issue, if not addressed, would lead to higher 
mortality rates. Furthermore, both groups agreed that 
the actions currently taken were too slow. Resistance 
itself however, is perceived differently by the two groups. 
Two programme managers did not think resistance is due 
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to failures of the interventions and programmes did not 
have many options once resistance did occur. However, 
a researcher pointed out that resistance was a failure as 
it was anticipated and counter measures happened too 
slowly.
The application of EM principles in malaria control 
programmes
There was disagreement amongst participants with 
respect to whether or not evolutionary principles are 
already being considered within control programmes. 
Whilst two programme managers said this was the case, 
others in both groups stated that this was not; the rea-
son given was the general lack of human and financial 
resources. It was stated by four participants that people 
working on the front line of malaria control were over-
burdened with the urgent task of reducing transmission, 
mortality and morbidity with the tools they had, evolu-
tionary approaches are therefore not given priority. One 
researcher emphasized that academics understood this 
problem and he agreed that interventions should be 
delayed for the sake of research. While two programme 
managers said it is logistically extremely difficult to con-
duct studies to make interventions evolution-proof, both 
sides saw the necessity to integrate EM principles to pro-
long the life span of control tools.
There were variable answers to the question whether 
EM principles are considered globally. Evolutionary plan-
ning was perceived by some of the interviewees as some-
thing to be considered long-term and globally, to make 
sure that the short-term achievements are not lost. Three 
participants from both groups said that, especially for 
drugs, evolutionary principles are taken into account 
by the WHO and their recommendations are imple-
mented into programmes. While other interviewees in 
both groups said that they are currently not incorporated 
because the main priority is getting coverage; only once 
transmission is reduced, other aspects can be considered.
Academics thought it was necessary for the public to 
know and understand that malaria control is a process 
and that there is no one simple lasting solution. How-
ever, one programme manager counter argued that it is 
difficult enough to get people to use control tools and 
take medicines; evolutionary information would only 
harm the process of getting quick and rapid coverage. 
Both academics and programme managers agreed that 
programmes do not have the resources to look into the 
future and try to do the best with the tools they have. 
Nevertheless, both groups agreed that researchers need 
to make control tools evolutionary-proof prolonging 
their effectiveness by making it difficult for vectors to 
develop resistance. A programme manager suggested 
placing some of the responsibility with researchers to 
develop new tools such as insecticides, that are not fast 
acting neurotoxins and do not kill immediately hence not 
putting a strong selection pressure on the vector.
Overall, it was acknowledged by the majority of mem-
bers of both groups that poor monitoring, lack of under-
standing, standard strategies applied continually and in 
different environments lead to interventions that may be 
more harmful than helpful by not taking the evolution-
ary history of the pathogen, vector and host into account. 
Both groups agreed on the fact that research results have 
to be made practical and that academics have to make 
them accessible and applicable for programmes.
One interviewee explained that programmes often do 
not run long enough to study the long-term effects inter-
ventions have on pathogen, vector, and host. Thus, the 
decision-makers fail to see the contribution EM princi-
ples could make. This view can be seen in the statements 
below:
“The way our programmes are structured we don’t 
take evolution into account because we are too short 
sighted, literally” (Programme Manager, Telephone 
interview, May 5, 2015).
“If I was a programme manager in an African coun-
try and I was severely hit by malaria and I had X 
access to X thousands of dollars I would probably 
choose to protect my population with whatever tools 
I have at the moment” (Programme Manager, Tel-
ephone interview, May 6, 2015).
“If you can reduce transmission by 50  % or even 
30  % then the tools have a better chance of work-
ing to prevent and eliminate malaria” (Programme 
Manager, Telephone interview, May 14, 2015).
Although the Multisection Action Framework for 
Malaria from RBM calls for collaboration from different 
sectors, results of this study indicate a general discon-
nect between academics and programme managers when 
it comes to evolutionary principles. One researcher said 
that it was important for people to realize that tools do 
not last forever as parasites and vectors evolve. While 
in contrast a programme manager pointed out that 
this kind of message would reduce trust in the control 
programmes.
Communication between academia and practical 
application
The information acquired from the interviews revealed 
a disconnection between the theoretical measures that 
would slow down resistance and sustain success, and 
what can practically be done. The interviews furthermore 
revealed some of the reasons for this and exposed the 
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lack of cooperation between the different groups. There 
were disagreements within the groups. Both the pro-
gramme manager group and academia group included 
people saying that communication already has been 
improved and some saying there is still a divide between 
these two sectors. Academics and programme manag-
ers complained about the lack of communication and 
cooperation between the groups. One of the interviewees 
shared their impression of an annual RBM meeting, stat-
ing that evolutionary presentations were so technical and 
mathematical that only about 20 % understood what was 
being said. Therefore, the information given was lost.
One of the researchers was frustrated that research 
results with possible important implications for malaria 
control was published in papers but not extended to 
the people who need to know. This participant argued 
that researchers need to take responsibility for commu-
nicating results in a simple and accessible manner. This 
opinion and the fact that the process of putting research 
into practice is currently taking too long was shared by 
other interviewees. The example of bed nets was often 
mentioned in the interviews; one academic saying it took 
25  years for bed nets to be distributed on a mass scale. 
There has to be a stronger cooperation between the dif-
ferent sectors for this process to go faster. This can be 
seen in the quote below:
“The issue there is probably the lack of integration 
of the different programmes. There is probably the 
tendency all over the world for everyone to work in 
their own little niche. […] What should matter most 
is taking the health and the wellbeing of communi-
ties at large without specializing in one specific area, 
health, education, tourism, finance or agriculture” 
(Programme Manager, Telephone interview, May 6, 
2015).
Programme managers and academics said that both 
sides have unrealistic expectations from each other. In 
order for co-operation to exist there needs to be more 
understanding for the limitations each group faces. Both 
agreed that people working in the field do not have time 
or financial resources to do research and scientists had to 
reach out with their findings. Both sides also agreed that 
every sector works in their own niche; lacking a collective 
goal and barriers needed to be removed so that people 
can work together.
Discussion
This study was started with no a priori expectations on 
the level of agreement or otherwise amongst partici-
pants. Disagreements were recorded in terms of the prac-
ticality and value of incorporating evolutionary principles 
into operational aspects of malaria control, but recorded 
a consensus that the principle is important for research 
and preventing resurgence. The reasons for this tension 
were partly uncovered in the responses given—seemingly 
there is a lack of understanding on both sides of the con-
straints impinged on the other side. The problem in many 
cases appears not to be a lack of stakeholder knowledge 
of the role of other actors, but the fact that potentially 
effective strategies towards more sustainable control 
cannot be implemented into programmes due to lack of 
funding, lack of human resources, poor infrastructure, 
lack of political will, poor collaboration between different 
sectors and poverty.
Participants agreed that resistance is a problem that 
arises because pathogens, vectors and humans co-evolve; 
and that it is the role of scientists to study this rela-
tionship and to develop and recommend new control 
methods. Interviewees collectively acknowledged that 
evolutionary principles have not been incorporated into 
current control efforts, and all participants agreed that 
control programmes cannot and should not be examin-
ing evolutionary principles. However, participants also 
agreed that evolutionary principles should not be disre-
garded from control programmes.
The results of the study are based on a convenience 
sample of practitioners and should be interpreted in 
that context. As a scoping exercise the aim was to test 
whether discussions on the subject would elicit mean-
ingfully differential responses. Nonetheless, from these 
results it can be initially inferred that some form of EM 
could have a role to play in promoting sustainable con-
trol of malaria. The basic premise of EM is that clinicians 
and other stakeholders are trained in principles of evolu-
tionary biology so that when faced with a health problem 
requiring a solution, they can reach into their personal 
knowledge base and use evolutionary principles to help 
inform their answer. Principles of EM can be used to 
interpret operational results [14] and also act as a con-
nection point between evolutionary theory and applied 
public health strategies to make these more effective and 
sustainable [14].
Elements of evolutionary theory have been previously 
applied in a several medical-research domains includ-
ing assessing the post-trial selection pressure potential 
of HIV vaccines [15], testing theories underpinning the 
aetiology of hypertension [16] and understanding how 
historic climate change may have selected for specific 
alleles involved in metabolic disorders [17].
In terms of malaria, basic-science research projects 
have identified a number of genetic factors correspond-
ing to acquired immunity [18]. Wider consideration of 
the evolutionary underpinnings of virulence, including 
negative selection [19] have led to the suggestion that an 
evidence-based resistance-management strategy taking 
Page 6 of 8Ocampo and Booth  Malar J  (2016) 15:383 
the absolute fitness of the parasite would ensure inter-
ventions are evolution-proof. This approach comple-
ments a suggestion by Read and colleagues [8] to target 
old, infected mosquitoes, so as to make resistance redun-
dant in terms of the reproductive success of the vector.
What is clear from these and other examples is that the 
inclusion of evolutionary theory into medically important 
domains of enquiry can give clearer insights at the level 
of research. For effective management of medical disor-
ders like those above, as well as any other disease that has 
developed as product of evolutionary processes, there are 
potential gains from transferring not just the knowledge 
gained from these studies but also a more basic under-
standing of the rationale and theory that underpins the 
investigation. This is where the basic framework of EM 
could assist.
One reason why EM has so far not been incorporated 
is possibly due to the process by which research results 
are translated into practice. At the level of basic research, 
caveats are discussed and made reasonably promi-
nent in the publications. But as results are translated 
into implementation research, those same caveats are 
often discussed less until they may all but disappear, to 
be replaced by targets once roll-out of a particular solu-
tion is undertaken by implementation organizations. The 
basic research continues, but as this study shows, it is 
often difficult for stakeholders, involved with programme 
management who may be recruited only at the imple-
mentation stage, to understand the science in the way it 
is presented. Even if they do understand the science, they 
may not be in a position to apply that knowledge due to 
the limitations of their role.
At the point of roll-out, budgets are set which may or 
may not be sufficient to deal with all contingencies. In 
this study, programme managers cited lack of funding 
within control budgets as the biggest challenge to sus-
tainable control of malaria. Cost, and particularly cost-
effectiveness, is clearly a major factor in determining the 
choice of a particular intervention. But even for estab-
lished interventions such as LLINs and indoor residual 
spraying, estimating the cost-effectiveness is far from 
straightforward due to a combination of factors related to 
such issues as local endemicity, climate, levels of immu-
nity, transactional costs, [20]. Long-term benefits of more 
expensive components of sustainable control such as 
monitoring and surveillance are also rarely considered 
[21]. This lack of wider considerations is perhaps the rea-
son why DDT, despite growing evidence of resistance, is 
still widely used as it is the cheapest insecticide [22].
Given that selection pressures are constantly acting on 
vectors and parasites, it seems sensible to suggest that 
any assessment of the cost-effectiveness of an interven-
tion should ideally incorporate scenarios that consider 
how a pathogen or its vector may adapt to selection pres-
sures imposed by the intervention. It may emerge during 
scenario planning that what appears to be a cost-effective 
approach in the short term is less effective on a ‘whole 
life-cycle’ basis. In this context, whole life-cycle cost cor-
responds to the time and cost of elimination of malaria 
from the point where basic research on a particular solu-
tion is started.
The so-called ‘arms race’ is a prominent evolution-
ary meme in drug-and insecticide development, but the 
anticipation of a problem does not in itself appear to be 
an agent for change. This point is made evident by the 
lack of attention given to any other potential solutions, 
beyond those in the current tool box [23], in the WHO 
malaria strategy 2016–30 [24] Multi-sectoral collabora-
tions between national malaria control programmes and 
researchers do occur and are undoubtedly helpful, but to 
what extent they are equipped to give agency to alterna-
tive strategies based on planning for evolutionary adapta-
tion is not always clear.
One issue that is being given agency in a collaboration 
at the research-control nexus is that of better housing. 
The potential for better housing to reduce malaria trans-
mission is entirely missing from the WHO malaria 2016–
30 strategy, despite being considered over 20 years ago in 
evolutionary terms. Ewald [25] argued improved housing 
conditions would place a selection pressure on the patho-
gen to become less virulent. Additionally, by not allowing 
the vector to come in contact with immobile and severely 
sick hosts, only mild strains would be transmitted [25]. A 
recent systematic review [26] confirmed that better hous-
ing reduces malaria risk, and also provided the evidence 
for a randomized controlled trial that involved a collabo-
ration between researchers and a national control pro-
gramme, in the Gambia [27].
Ewald [25] acknowledged that building houses is more 
costly than distributing bed nets whilst suggesting it is 
more efficient in reducing transmission. Had this concept 
been tested contemporaneously with its generation, the 
malaria control community may have headed down a dif-
ferent implementation route, or considered housing ear-
lier in the intervention time line.
Conclusion
The results of this scoping project suggest that the cur-
rent tension between theory and practice, revealed by 
participants, may be contributing to a lack of mitigation 
strategies against drug and insecticide resistance—issues 
which can ultimately cause programmes to fail [2, 28]. 
Parasite, vector and host are under constant selection 
pressure that they put on each other [12, 13]. Widespread 
knowledge of this phenomenon is a key part of includ-
ing EM at the research-control nexus. The results of the 
Page 7 of 8Ocampo and Booth  Malar J  (2016) 15:383 
interviews indicate that whilst the idea of EM is not gen-
erally objected, the lack of effective monitoring and col-
laboration between the different sectors and the lack of 
political will from local governments make it currently 
difficult to incorporate.
Participants agreed that the role of scientists was not 
only to carry out evolutionary research, but also make it 
accessible and applicable to programme managers. One 
suggestion from this study is that programme manag-
ers would benefit from earlier exposure to the research 
agenda, and training in evolutionary theory at an appro-
priate level. Determining the ‘appropriate level’ will 
require work in itself. The main recommendation from 
this project is, therefore, that co-ordinating organiza-
tions, including WHO and the Centers for Disease Con-
trol and Prevention, alongside scientists and programme 
managers, investigate how to incorporate EM at the 
research-control nexus. This may be achieved through 
applying methods of co-production [29]—a process 
that goes beyond knowledge transfer to bring together 
academics and all other stakeholders earlier on in the 
research process. It will be important during this process 
to not lose sight of the caveats, as EM is not a panacea.
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